Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03410134
Other study ID # Irreversible pulpitis
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date August 1, 2023

Study information

Verified date March 2021
Source Hacettepe University
Contact Zafer C Cehreli, Prof
Phone 00905353197969
Email zcehreli@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the long term clinical performance of vital pulp therapy of young permanent teeth with irreversible pulpitis


Description:

Permanent molar teeth meeting the inclusion criteria will be included into the study. Following local anaesthesia and dental dam application, caries excavation will be performed; and after exposure, the pulp will be amputated to the level of the canal orifices (full pulpotomy) using a sterile high-speed round bur under water coolant. After haemostasis is achieved, Mineral trioxide aggregate (MTA) will be gently placed over the pulp to a thickness of 2-3 mm and the tooth will be restored using glass ionomer cement and composite resin. A postoperative periapical radiograph will be taken. Patients will be reviewed at 6., 12., 24. and 36. months for clinical and radiographical success. The data will be analysed statistically using chi square test.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date August 1, 2023
Est. primary completion date August 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria: - Patients and parents of the patients who accept to participate and sign the informed consent - Patients who have at least one vital permanent molar teeth with irreversible pulpitis symptoms - Teeth which can be restorable after the treatment. - Teeth which has good periodontal health and in the absence of sinus tracts or swelling. Exclusion Criteria: - Patients and parents of the patients who does not accept to participate and sign the informed consent - Teeth which have dentoalveolar or extraoral swelling - Teeth which have periodontal disease, mobility or alveolar bone loss - Teeth which are not restorable - Patients who are not cooperative with the treatment

Study Design


Intervention

Device:
NeoMTA
NeoMTA™ Plus® root and pulp treatment material is a powder/gel system with no resin. The components are an extremely fine powder primarily tricalcium and dicalcium silicate plus a water-based gel.

Locations

Country Name City State
Turkey Hacettepe University Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Asgary S, Eghbal MJ, Ghoddusi J, Yazdani S. One-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial. Clin Oral Investig. 2013 Mar;17(2):431-9. doi: 10.1007/s00784-012-0712-6. Epub 2012 Mar 21. — View Citation

Qudeimat MA, Alyahya A, Hasan AA. Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study. Int Endod J. 2017 Feb;50(2):126-134. doi: 10.1111/iej.12614. Epub 2016 Feb 22. — View Citation

Taha NA, Ahmad MB, Ghanim A. Assessment of Mineral Trioxide Aggregate pulpotomy in mature permanent teeth with carious exposures. Int Endod J. 2017 Feb;50(2):117-125. doi: 10.1111/iej.12605. Epub 2016 Jan 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical evaluation of vital pulp therapy in permanent teeth with irreversible pulpitis Long-term success of vital pulp therapy in young permanent teeth with irreversible pulpitis. Evaluation criteria will be;
spontaneous pain (absent/present);
tenderness to percussion/palpation (absent/present);
mobility (no mobility/ 1mm/ 2mm/ 3mm mobility)
swelling (absent/present);
fistula (absent/present)
periapical/interradicular radiolucency (absent/present);
widened periodontal ligament (absent/present);
loss of lamina dura (absent/present);
internal/external root resorption (absent/present).
3 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05981352 - Evaluation of Different Materials in Pulpotomy of Primary Molars N/A
Recruiting NCT06227390 - Clinical and Radiographic Outcomes of Partial Pulpotomy Procedure in Primary Molars Utilizing Different Capping Materials and Different Restorative Methods N/A
Completed NCT06398327 - Efficacy Of Proinflammatory Cytokines in The Primary Molar Pulpotomy N/A
Recruiting NCT03883295 - Evaluation of Clinical and Radiological Success of Vital Amputation Treatment N/A
Active, not recruiting NCT03580135 - Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars Phase 2
Recruiting NCT04793477 - Effectiveness of Rotating System and Single File Reciprocating System in Temporal Molars N/A
Completed NCT04274920 - Dentin Bridge Formation After Indirect Pulp Capping With Bioactive Glass Incorporated in Resin Composite and Its Adhesive in Comparison With Light Cured Calcium Hydroxide N/A
Not yet recruiting NCT05839548 - Articaine Efficacy and Safety for 3 Years Old Children Phase 3
Active, not recruiting NCT05912907 - Potassium Nitrate in Polycarboxylate as a Direct Pulp Capping N/A
Completed NCT05633537 - Clinical & Radiographic Evaluation of Zinc Oxide-Ozonated Oil as a New Primary Root Canal Filling N/A
Completed NCT06110494 - A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment Phase 4
Completed NCT03542019 - Survival of Endocrowns Made From Different Ceramics N/A
Completed NCT06002646 - Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques Phase 4
Not yet recruiting NCT03368391 - : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic Phase 4
Recruiting NCT06196515 - Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication Phase 2/Phase 3
Not yet recruiting NCT04650113 - Clinical and Radiographic Assessment of Partial and Complete Pulpotomy in Primary Molars Using MTA Phase 1/Phase 2
Completed NCT06129643 - Post-operative Pain After Laser Root Canal Treatment of Necrotic Teeth With Apical Periodontitis Phase 2
Recruiting NCT06207253 - The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament Phase 2/Phase 3
Completed NCT03582319 - Clinical and Radiographic Evaluation of Biodentine Versus Formocresol N/A
Not yet recruiting NCT06170775 - Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth N/A